Home » Medical Devices » UK Peripheral Vascular Devices Market

UK Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 68821 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
UK Peripheral Vascular Devices Market Size 2023 USD 417.16 million
UK Peripheral Vascular Devices Market, CAGR 6.51%
UK Peripheral Vascular Devices Market Size 2032 USD 690.90 million

Market Overview

The UK Peripheral Vascular Devices Market is projected to grow from USD 417.16 million in 2023 to USD 690.90 million by 2032, at a CAGR of 6.51%.

The growth of the UK Peripheral Vascular Devices market is driven by the increasing prevalence of peripheral artery diseases (PAD) and diabetes, which contribute to higher demand for effective treatment solutions. Advancements in technology have also spurred market expansion, with innovations in minimally invasive procedures and device efficiency offering better patient outcomes. The aging population in the UK, coupled with a rise in lifestyle-related health conditions, further fuels the demand for these devices. Additionally, government initiatives aimed at improving healthcare access and the growing adoption of healthcare technologies by medical professionals are creating a favorable environment for market growth. On the trend front, the market is seeing a shift toward more sophisticated, user-friendly, and cost-effective devices, reflecting the evolving needs of both healthcare providers and patients. These factors, combined with increasing awareness of vascular health, are expected to drive sustained growth in the UK Peripheral Vascular Devices market.

The UK Peripheral Vascular Devices market is driven by key regions such as London, Manchester, Scotland, and Birmingham, each contributing to the increasing demand for advanced vascular treatments. London remains a hub for innovation, housing world-class healthcare institutions and research centers. Manchester follows with its expanding medical facilities and academic influence, while Scotland’s strong healthcare system and aging population continue to support growth in vascular treatments. Birmingham’s growing infrastructure and demand for minimally invasive procedures further enhance the market landscape. Leading players in the UK market include Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, and Cook Medical, among others. These companies are continuously innovating to offer advanced peripheral vascular devices, driving the growth of the market with cutting-edge technology and improved patient outcomes.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The UK Peripheral Vascular Devices market is valued at USD 417.16 million in 2023 and is projected to reach USD 690.90 million by 2032, with a CAGR of 6.51%.
  • The rising prevalence of peripheral artery disease (PAD) and cardiovascular conditions is driving the demand for peripheral vascular devices.
  • Technological advancements in devices such as drug-eluting stents and angioplasty balloons are contributing to market growth.
  • The increasing adoption of minimally invasive procedures is shaping the market trends, leading to faster recovery and reduced complications.
  • Key players in the market include Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, and Boston Scientific Corporation, competing with innovative technologies.
  • High regulatory requirements and reimbursement challenges are restraining the growth of the market.
  • Regions like London and Manchester dominate the market, with growing demand from hospitals, ambulatory surgical centers, and specialty clinics.

Market Drivers

Advancements in Medical Technology

Technological advancements in medical devices are significantly driving the UK Peripheral Vascular Devices market. The development of next-generation, minimally invasive tools has enhanced treatment outcomes and reduced recovery times, leading to higher adoption rates among healthcare providers. For instance, in March 2024, clinical trials were initiated to evaluate novel vascular covered stents for treating PAD across multiple sites in the UK, Europe, Australia, and New Zealand. Innovations, such as drug-eluting stents and improved balloon catheters, have improved the success rates of procedures and increased patient satisfaction, contributing to the growing demand for these devices in clinical settings.

Supportive Government Initiatives and Healthcare Advancements

Government initiatives aimed at improving healthcare accessibility and promoting advanced medical treatments are also fueling the growth of the UK Peripheral Vascular Devices market. Public health campaigns focused on vascular health and increasing healthcare budgets to support innovative medical technologies are key drivers. For instance, the Health Tech Adoption and Acceleration Fund has provided £30 million to support the implementation of innovative technologies across 42 Integrated Care Systems. These initiatives are creating a conducive environment for market expansion, as hospitals and clinics are increasingly investing in the latest vascular devices to meet the growing demand for effective treatment options.

Growing Prevalence of Peripheral Artery Diseases (PAD)

The rising incidence of peripheral artery diseases (PAD) in the UK is a key driver for the demand for peripheral vascular devices. PAD, which is common among the aging population and those with lifestyle diseases such as diabetes, often requires intervention through devices such as stents, catheters, and balloons. As the number of PAD cases continues to increase, there is a greater need for effective and minimally invasive treatment options, thereby boosting the market for peripheral vascular devices.

Aging Population and Lifestyle Factors

The aging population in the UK plays a crucial role in driving market growth for peripheral vascular devices. As people age, they are more likely to develop vascular-related health issues such as PAD. Moreover, the rise in lifestyle-related risk factors, including smoking, sedentary behavior, and poor diet, has contributed to an increased prevalence of vascular diseases. These factors are creating a larger patient base that requires interventions using peripheral vascular devices, further expanding the market.

Market Trends

Focus on Patient-Centered Solutions

There is a growing trend towards developing patient-centered peripheral vascular devices that prioritize comfort, ease of use, and improved clinical outcomes. Manufacturers are focusing on creating devices that are not only technologically advanced but also provide a better overall experience for patients. Features such as smaller, more ergonomic designs, reduced risk of complications, and improved patient comfort are driving innovations in the market. For instance, the British Journal of Nursing highlights the development of peripheral intravenous catheters (PIVCs) that are designed to minimize discomfort and reduce the risk of infection. As patients increasingly demand higher-quality, personalized care, this trend toward more patient-friendly devices is shaping the development of new products in the peripheral vascular devices sector.

Shift Toward Minimally Invasive Procedures

A prominent trend in the UK Peripheral Vascular Devices market is the increasing preference for minimally invasive procedures. As healthcare providers aim to improve patient outcomes and reduce recovery times, devices that enable less invasive interventions are becoming more popular. These procedures, such as angioplasty and stenting, offer shorter hospital stays, reduced risk of complications, and quicker recovery, making them more appealing to both patients and clinicians. The shift toward minimally invasive solutions is driving demand for more advanced, user-friendly peripheral vascular devices.

Rising Demand for Cost-Effective Solutions

Cost-effectiveness has become an important consideration in the UK Peripheral Vascular Devices market. Healthcare systems are under pressure to reduce costs while maintaining high standards of care. As a result, there is a growing demand for devices that offer high clinical effectiveness at a lower cost. Manufacturers are focusing on creating cost-efficient solutions without compromising on performance, enabling healthcare providers to offer quality care while managing budget constraints. For example, the National Institute for Health and Care Excellence (NICE) has evaluated the cost-effectiveness of various peripheral vascular devices, promoting those that provide significant clinical benefits at lower costs. This trend is contributing to the increasing adoption of peripheral vascular devices in both public and private healthcare sectors.

Integration of Digital Technology

The integration of digital technology into peripheral vascular devices is another key trend shaping the market. Devices with enhanced digital features, such as real-time monitoring, image-guided intervention, and remote diagnostics, are becoming increasingly common. These technological advancements enable healthcare professionals to make more accurate and timely decisions, improving treatment precision. Digital technology also offers patients a better overall experience, with features that allow for improved monitoring of their conditions and outcomes. This trend is enhancing the effectiveness of vascular treatments and expanding the adoption of these devices in healthcare settings.

Market Challenges Analysis

Regulatory and Reimbursement Challenges

One of the significant challenges facing the UK Peripheral Vascular Devices market is the complex regulatory environment and reimbursement issues. The approval process for medical devices, including peripheral vascular devices, involves strict regulatory requirements, which can lead to delays in product launches and increased costs for manufacturers. For instance, obtaining approval from the Medicines and Healthcare products Regulatory Agency (MHRA) can take several months and requires extensive clinical trials. The need for extensive clinical trials and compliance with stringent safety standards can create barriers to entry for new players. Additionally, the reimbursement policies for these devices are evolving, and healthcare providers must navigate changing regulations and funding criteria. This uncertainty in reimbursement structures often impacts the adoption rates of newer devices and may limit market growth, especially for smaller healthcare providers who may face financial constraints.

High Competition and Pricing Pressures

The UK Peripheral Vascular Devices market is highly competitive, with numerous established players and an increasing number of new entrants offering a wide range of products. This intense competition puts pricing pressure on manufacturers, forcing them to find ways to offer high-quality products while reducing costs. While innovation in technology continues, manufacturers must balance the demand for advanced devices with the need to remain price-competitive in a cost-sensitive healthcare environment. As a result, pricing pressure can hinder profit margins, especially when healthcare systems are under financial constraints, impacting the ability of companies to invest in research and development or expand their market share. This competitive landscape presents a continuous challenge for companies to differentiate themselves and maintain sustainable growth.

Market Opportunities

Expansion in Aging Population and Chronic Diseases

A key opportunity for the UK Peripheral Vascular Devices market lies in the growing aging population and the increasing prevalence of chronic diseases, particularly diabetes and cardiovascular conditions. As the elderly population continues to rise, the demand for peripheral vascular devices to treat age-related conditions like peripheral artery disease (PAD) is expected to grow significantly. Additionally, lifestyle-related risk factors such as smoking, sedentary behavior, and poor diet continue to contribute to an increase in vascular health problems. This trend offers manufacturers the opportunity to develop and market advanced devices that address the needs of a larger patient base, ensuring better treatment outcomes and improved quality of life for individuals affected by these conditions.

Advancements in Technology and Healthcare Integration

Another promising opportunity lies in the integration of advanced technologies into peripheral vascular devices. Innovations such as image-guided interventions, real-time monitoring, and digital integration are shaping the future of vascular treatments. These technological advancements present opportunities for device manufacturers to offer more effective, minimally invasive solutions that enhance patient care and improve clinical outcomes. Furthermore, as the UK healthcare system increasingly adopts digital solutions and smart technologies, there is an opportunity to introduce devices that align with these trends. The growing focus on personalized medicine also creates an avenue for the development of tailored, patient-specific vascular devices. Manufacturers that leverage these innovations and integrate them into their product offerings stand to capture a greater share of the growing market, driven by enhanced treatment efficiency and patient satisfaction.

Market Segmentation Analysis:

By Type:

The UK Peripheral Vascular Devices market is categorized by various device types, including angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and angioplasty stents hold the largest market share, driven by their widespread use in treating peripheral artery disease (PAD) through minimally invasive procedures. Angioplasty balloons are designed to dilate narrowed arteries, while stents provide structural support to keep vessels open after angioplasty. Catheters and guidewires, essential for accessing vascular structures, also represent significant market segments due to their crucial role in a variety of interventional procedures. Other devices, such as thrombectomy devices and atherectomy tools, are gaining traction as additional treatment options for PAD. The continued advancement in device technology, offering enhanced performance and patient outcomes, contributes to the growth of these segments, with a shift towards minimally invasive and effective alternatives to traditional surgery.

By End-user:

The UK Peripheral Vascular Devices market is also segmented based on end-users, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals dominate the market due to their comprehensive healthcare services and the higher volume of PAD and vascular procedures performed in these settings. ASCs, however, are experiencing significant growth, driven by their ability to offer cost-effective and efficient treatments in a more outpatient-focused environment. The increasing adoption of minimally invasive procedures in ASCs is contributing to this growth. Specialty clinics focusing on vascular health are another key segment, benefiting from the rising demand for specialized care and targeted treatments for vascular diseases. These clinics are positioned to offer advanced, patient-specific therapies, further expanding the market for peripheral vascular devices. As healthcare systems evolve and demand for specialized, outpatient-based care increases, these end-user segments are expected to grow rapidly.

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • London
  • Manchester
  • Birmingham
  • Scotland

Regional Analysis

London

London holds approximately 40% of the market share, driven by its advanced healthcare infrastructure, a high concentration of hospitals, and specialized medical centers. London’s dominance in the Peripheral Vascular Devices market can be attributed to its status as a global medical hub. With world-class hospitals, specialized clinics, and research centers, the city serves as the epicenter for innovation in the healthcare sector. The high volume of vascular surgeries and interventions conducted in leading healthcare institutions like St Thomas’ Hospital and King’s College Hospital contributes significantly to the region’s market share. Additionally, London’s aging population, combined with increasing prevalence of lifestyle-related vascular diseases, further fuels the demand for peripheral vascular devices. The integration of advanced medical technologies and personalized treatment options further strengthens the market in this region.

Manchester

Manchester has steadily gained market share in the UK Peripheral Vascular Devices market, currently holding approximately 25% of the market. The city’s prominent medical and academic institutions, such as the Manchester Royal Infirmary, play a key role in advancing research and improving patient outcomes in peripheral vascular disease treatments. With a growing focus on minimally invasive procedures, Manchester’s healthcare system has adopted innovative vascular devices, which has contributed to a rise in the number of interventions performed annually. Additionally, the region’s strategic initiatives aimed at improving healthcare access and quality are helping boost the demand for peripheral vascular devices.

Scotland

Scotland, with a market share of approximately 15%, is also seeing significant growth in the demand for peripheral vascular devices. Scotland’s healthcare system has undergone considerable modernization, with hospitals like the Royal Infirmary of Edinburgh and Glasgow’s Queen Elizabeth University Hospital offering specialized vascular treatments. The region’s increasing focus on improving healthcare access, coupled with an aging population, is driving the adoption of advanced vascular devices. With an expanding network of ambulatory surgical centers and specialty clinics, Scotland’s market is poised for continued growth. The rise in peripheral artery disease cases, combined with Scotland’s strong commitment to improving healthcare outcomes, offers significant opportunities for peripheral vascular device manufacturers.

Birmingham

Birmingham, holding a market share of around 10%, is gradually becoming an important player in the UK’s peripheral vascular devices market. The city is home to several leading hospitals, including the Queen Elizabeth Hospital, which offers a comprehensive range of vascular treatments. As the second-largest city in the UK, Birmingham is experiencing an increase in both its aging population and the number of patients seeking vascular interventions. The growing adoption of minimally invasive technologies and the establishment of specialized vascular clinics in the city further contribute to market growth. With an expanding healthcare infrastructure and a rising demand for effective treatment solutions, Birmingham’s market share is expected to grow in the coming years.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Player Analysis

  • Medtronic plc
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Cook Medical
  • Straub Medical AG
  • Eurocor Tech GmbH
  • AngioDynamics, Inc.

Competitive Analysis

The UK Peripheral Vascular Devices market is highly competitive, with leading players focusing on product innovation, technological advancements, and strategic collaborations to strengthen their market position. Major companies such as Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Cook Medical, Straub Medical AG, Eurocor Tech GmbH, and AngioDynamics, Inc. are prominent players in the market. Leading players are continuously investing in research and development to offer cutting-edge solutions such as drug-eluting stents, angioplasty balloons, guidewires, and other minimally invasive devices. For instance, Medtronic has significantly increased its research and development funding, receiving $337 million from Blackstone Life Sciences to advance its diabetes technologies. Technological improvements, such as the integration of digital features like real-time monitoring and image-guided interventions, have become key differentiators. Manufacturers are also expanding their product portfolios to cater to the growing demand for patient-specific treatments and improved clinical outcomes. Companies are leveraging mergers, acquisitions, and collaborations to enhance their market reach and strengthen their position in the competitive landscape. Additionally, efforts to reduce production costs without compromising quality are gaining importance, allowing for more cost-effective solutions to be offered to healthcare providers. The intense competition fosters continuous innovation and better treatment options for patients, ultimately driving the market forward. Companies must also navigate complex regulatory frameworks and reimbursement challenges to ensure widespread adoption of their devices.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The UK Peripheral Vascular Devices market is moderately concentrated, with a mix of established global players and emerging companies vying for market share. While a few large companies dominate the landscape, the presence of numerous smaller players and specialized manufacturers creates a competitive environment. These dominant players focus on innovation, research and development, and expanding their product portfolios to include a wide range of peripheral vascular devices, such as angioplasty balloons, stents, catheters, and guidewires. The market characteristics are marked by a high level of technological advancement, with many companies investing in minimally invasive devices that offer better patient outcomes, shorter recovery times, and reduced complications. Additionally, regulatory standards and reimbursement policies heavily influence market dynamics, as companies must comply with strict requirements to gain market approval and widespread adoption. There is a growing trend towards personalized medicine and the integration of digital technologies into peripheral vascular devices, allowing for more precise and effective treatments. The market is also witnessing the emergence of advanced materials, such as drug-eluting stents, which further contribute to device innovation. Despite the dominance of large companies, smaller players continue to challenge the status quo, fostering healthy competition and pushing the market towards continuous technological improvement and improved clinical solutions.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The UK Peripheral Vascular Devices market is expected to grow significantly due to the increasing prevalence of cardiovascular diseases and peripheral artery disease (PAD).
  2. Technological advancements in minimally invasive procedures will drive demand for more efficient and effective vascular devices.
  3. The adoption of drug-eluting stents and bioresorbable scaffolds will revolutionize treatment options and patient outcomes.
  4. Increasing investment in research and development will lead to innovative device designs and improved functionalities.
  5. The aging population in the UK will continue to fuel the need for advanced vascular treatment options.
  6. Growing healthcare expenditure and improved access to healthcare services will contribute to market expansion.
  7. Regulatory frameworks are likely to evolve, creating both opportunities and challenges for manufacturers in device approval and market entry.
  8. The rise of outpatient care and ambulatory surgical centers will increase demand for cost-effective, minimally invasive vascular devices.
  9. Digital integration and real-time monitoring in devices will enhance treatment accuracy and patient care.
  10. Companies will focus on expanding their product portfolios and forming strategic partnerships to maintain competitive advantages in the evolving market.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Peripheral Vascular Devices Market Snapshot 21

2.1.1. UK Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 25

4.2.2. Technological advancements in minimally invasive procedures 26

4.3. Market Restraints 27

4.3.1. High cost of peripheral vascular devices and associated procedures 27

4.4. Market Opportunities 28

4.4.1. Growing demand for peripheral vascular devices in emerging economies 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by UK 31

5.1.1. UK Peripheral Vascular Devices Market Import Volume/Revenue, By UK, 2018 – 2023 31

5.2. Export Analysis by UK 32

5.2.1. UK Peripheral Vascular Devices Market Export Volume/Revenue, By UK, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by UK 33

6.1.1. UK Peripheral Vascular Devices Market Demand Volume/Revenue, By UK, 2018 – 2023 33

6.2. Supply Analysis by UK 34

6.2.1. UK Peripheral Vascular Devices Market Supply Volume/Revenue, By UK, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by UK 35

7.1.1. UK Peripheral Vascular Devices Market Production Volume/Revenue, By UK, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. UK Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

8.1.2. UK Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. UK Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 40

11.2.2. UK Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 41

11.2.3. UK Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. UK Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. UK Peripheral Vascular Devices Market Company Volume Market Share, 2023 43

11.4. UK Peripheral Vascular Devices Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

UK Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Peripheral Vascular Devices Market Overview, by Type Segment 49

13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Angioplasty Balloons 53

13.3. Angioplasty Stents 54

13.4. Catheters 55

13.5. Guidewires 56

13.6. Others 57

CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 58

14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 58

14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 60

14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60

14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

14.2. Hospitals 62

14.3. Ambulatory Surgical Centers 63

14.4. Specialty Clinics 64

CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – UK ANALYSIS 65

15.1. Type 65

15.1.1. UK Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

15.2. UK Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

15.3. End-user 66

15.3.1. UK Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

15.3.2. UK Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

CHAPTER NO. 16 : COMPANY PROFILES 67

16.1. Medtronic plc 67

16.1.1. Company Overview 67

16.1.2. Product Portfolio 67

16.1.3. Swot Analysis 67

16.1.4. Business Strategy 68

16.1.5. Financial Overview 68

16.2. Becton, Dickinson and Company 69

16.3. Biotronik SE & Co. KG 69

16.4. Koninklijke Philips N.V. 69

16.5. Boston Scientific Corporation 69

16.6. Terumo Corporation 69

16.7. Cook Medical 69

16.8. Straub Medical AG 69

16.9. Eurocor Tech GmbH 69

16.10. AngioDynamics, Inc. 69

List of Figures

FIG NO. 1. UK Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for UK Peripheral Vascular Devices Market 29

FIG NO. 3. UK Peripheral Vascular Devices Market Import Volume/Revenue, By UK, 2018 – 2023 31

FIG NO. 4. UK Peripheral Vascular Devices Market Export Volume/Revenue, By UK, 2018 – 2023 32

FIG NO. 5. UK Peripheral Vascular Devices Market Demand Volume/Revenue, By UK, 2018 – 2023 33

FIG NO. 6. UK Peripheral Vascular Devices Market Supply Volume/Revenue, By UK, 2018 – 2023 34

FIG NO. 7. UK Peripheral Vascular Devices Market Production Volume/Revenue, By UK, 2018 – 2023 35

FIG NO. 8. UK Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for UK Peripheral Vascular Devices Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peripheral Vascular Devices Market – Company Volume  Market Share, 2023 43

FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. UK Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. UK Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. UK Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. UK Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. UK Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By End-user 60

FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60

FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

FIG NO. 32. UK Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. UK Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. UK Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables

TABLE NO. 1. : UK Peripheral Vascular Devices Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27

TABLE NO. 4. : UK Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : UK Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

TABLE NO. 7. : UK Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

TABLE NO. 8. : UK Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

TABLE NO. 9. : UK Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

 

Frequently Asked Questions

What is the current size of the UK Peripheral Vascular Devices market?

The UK Peripheral Vascular Devices market is valued at USD 417.16 million in 2023 and is projected to reach USD 690.90 million by 2032, growing at a compound annual growth rate (CAGR) of 6.51%.

What factors are driving the growth of the UK Peripheral Vascular Devices market?

Key factors driving the market growth include the rising prevalence of peripheral artery diseases (PAD) and diabetes, advancements in minimally invasive medical technologies, a growing aging population, and government initiatives to improve healthcare accessibility and adoption of innovative treatment solutions.

What are the key segments within the UK Peripheral Vascular Devices market?

The market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. By end-user, it is divided into hospitals, ambulatory surgical centers, and specialty clinics. Geographically, key regions include London, Manchester, Scotland, and Birmingham.

What are some challenges faced by the UK Peripheral Vascular Devices market?

Challenges include complex regulatory requirements, delays in device approvals, reimbursement challenges, and intense competition leading to pricing pressures. These factors can impact product launches, market penetration, and overall profitability for manufacturers.

UK AC-DC Power Supply in Data Center Market

Published:
Report ID: 75679

UK Meat Processing Equipment Market

Published:
Report ID: 75594

UK Meat Enhancer Market

Published:
Report ID: 75601

UK Data Center Processor Market

Published:
Report ID: 74989

UK High-End Beef Market

Published:
Report ID: 74804

UK Large Language Model Powered Tools Market

Published:
Report ID: 74798

UK Interior Design Market

Published:
Report ID: 74681

UK Cloud Professional Services Market

Published:
Report ID: 73783

UK Data Center Security Market

Published:
Report ID: 73768

South Africa Medical Gas and Equipment Market

Published:
Report ID: 75642

Compliance Monitoring Devices Market

Published:
Report ID: 75564

Continuous Glucose Monitoring Devices Market

Published:
Report ID: 4258

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Malignant Pleural Effusion Market

Published:
Report ID: 74366

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN